Original Articles
The validity of recommendations from clinical guidelines: a survival analysis
Laura Martínez García, Andrea Juliana Sanabria, Elvira García Álvarez, Maria Mar Trujillo-Martín, Itziar Etxeandia-Ikobaltzeta, Anna Kotzeva, David Rigau, Arturo Louro-González, Leticia Barajas-Nava, Petra Díaz del Campo, Maria-Dolors Estrada, Ivan Solà, Javier Gracia, Flavia Salcedo-Fernandez, Jennifer Lawson, R. Brian Haynes, Pablo Alonso-Coello and for the Updating Guidelines Working Group
CMAJ September 08, 2014 cmaj.140547; DOI: https://doi.org/10.1503/cmaj.140547
Laura Martínez García
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Andrea Juliana Sanabria
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Elvira García Álvarez
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Maria Mar Trujillo-Martín
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Itziar Etxeandia-Ikobaltzeta
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Anna Kotzeva
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
David Rigau
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Arturo Louro-González
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Leticia Barajas-Nava
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Petra Díaz del Campo
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Maria-Dolors Estrada
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Ivan Solà
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Javier Gracia
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Flavia Salcedo-Fernandez
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Jennifer Lawson
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
R. Brian Haynes
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Pablo Alonso-Coello
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.
Iberoamerican Cochrane Centre and Biomedical Research Institute Sant Pau (IIB Sant Pau) (García, Sanabria, Rigau, Barajas-Nava, Solà, Alonso-Coello), Barcelona, Spain; NHS Ayrshire and Arran (García Álvarez), Ayr, United Kingdom; Fundacion Canaria de Investigacion y Salud (FUNCIS), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC) (Trujillo-Martín), Tenerife, Spain; Osteba, and Basque Office for Health Technology Assessment (Etxeandia-Ikobaltzeta), Vitoria, Spain; Agency for Health Quality and Assessment of Catalonia (AQuAS) (Kotzeva, Estrada), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP) (Kotzeva, Estrada, Solà, Alonso-Coello), Barcelona, Spain; Centro de Saude de Cambre, Xerencia de Xestion Integrada de A Coruna SERGAS (Louro-González), A Coruna, Spain; Health Technology Assessment Unit (UETS), Subdireccion General de Tecnología e Innovacion Sanitaria, Consejería de Sanidad (Díaz del Campo), Madrid, Spain; National Clinical Practice Guideline Programme of the NHS (Gracia), Madrid, Spain; GuíaSalud-Aragon Institute of Health Sciences (Salcedo -Fernandez), Zaragoza, Spain; Department of Clinical Epidemiology and Biostatistics, McMaster University, (Lawson, Haynes), Hamilton, Ont.